Beata Berent-Maoz
Beata Berent-Maoz
Verified email at
Cited by
Cited by
Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma
W Hugo, JM Zaretsky, LU Sun, C Song, BH Moreno, S Hu-Lieskovan, ...
Cell 165 (1), 35-44, 2016
Mutations associated with acquired resistance to PD-1 blockade in melanoma
JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ...
New England Journal of Medicine 375 (9), 819-829, 2016
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ...
Cancer discovery 7 (2), 188-201, 2017
Causes, consequences, and reversal of immune system aging
E Montecino-Rodriguez, B Berent-Maoz, K Dorshkind
The Journal of clinical investigation 123 (3), 958-965, 2013
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov. 2017; 7: 188–201. doi: 10.1158/2159-8290
DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ...
CD-16-1223.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
Immunotherapy resistance by inflammation-induced dedifferentiation
A Mehta, YJ Kim, L Robert, J Tsoi, B Comin-Anduix, B Berent-Maoz, ...
Cancer discovery 8 (8), 935-943, 2018
Human Mast Cell Activation by Staphylococcus aureus: Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 …
CM Rocha-de-Souza, B Berent-Maoz, D Mankuta, AE Moses, ...
Infection and immunity 76 (10), 4489-4497, 2008
Overcoming genetically based resistance mechanisms to PD-1 blockade
DY Torrejon, G Abril-Rodriguez, AS Champhekar, J Tsoi, KM Campbell, ...
Cancer discovery 10 (8), 1140-1157, 2020
PAK4 inhibition improves PD-1 blockade immunotherapy
G Abril-Rodriguez, DY Torrejon, W Liu, JM Zaretsky, TS Nowicki, J Tsoi, ...
Nature Cancer 1 (1), 46-58, 2020
A pilot trial of the combination of transgenic NY-ESO-1–reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab
TS Nowicki, B Berent-Maoz, G Cheung-Lau, RR Huang, X Wang, J Tsoi, ...
Clinical Cancer Research 25 (7), 2096-2108, 2019
Are we ready to downregulate mast cells?
L Karra, B Berent-Maoz, M Ben-Zimra, F Levi-Schaffer
Current opinion in immunology 21 (6), 708-714, 2009
Distinct genetic networks orchestrate the emergence of specific waves of fetal and adult B-1 and B-2 development
E Montecino-Rodriguez, M Fice, D Casero, B Berent-Maoz, CL Barber, ...
Immunity 45 (3), 527-539, 2016
Development of hematopoietic stem cell-engineered invariant natural killer T cell therapy for cancer
Y Zhu, DJ Smith, Y Zhou, YR Li, J Yu, D Lee, YC Wang, S Di Biase, ...
Cell Stem Cell 25 (4), 542-557. e9, 2019
Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a
I Bachelet, A Munitz, B Berent-Maoz, D Mankuta, F Levi-Schaffer
The Journal of Immunology 180 (9), 6064-6069, 2008
Human mast cells undergo TRAIL-induced apoptosis
B Berent-Maoz, AM Piliponsky, I Daigle, HU Simon, F Levi-Schaffer
The Journal of Immunology 176 (4), 2272-2278, 2006
Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a
B Berent-Maoz, E Montecino-Rodriguez, RAJ Signer, K Dorshkind
Blood, The Journal of the American Society of Hematology 119 (24), 5715-5721, 2012
Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease
FR Melo, F Vita, B Berent-Maoz, F Levi-Schaffer, G Zabucchi, G Pejler
Journal of Biological Chemistry 289 (11), 7682-7690, 2014
CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma
SM Larson, CM Walthers, B Ji, SN Ghafouri, J Naparstek, J Trent, ...
Cancer discovery 13 (3), 580-597, 2023
Genetic regulation of thymocyte progenitor aging
B Berent-Maoz, E Montecino-Rodriguez, K Dorshkind
Seminars in immunology 24 (5), 303-308, 2012
The system can't perform the operation now. Try again later.
Articles 1–20